Case Study: a biopharma company streamlines ADA study reporting with IDBS E-WorkBook

Biopharma Company saves at least one day per study report with IDBS

A biopharma company was facing challenges with its immunogenicity testing process, where manual data compilation in Excel from its LIMS platform was time-consuming and error-prone. This process, which supported anti-drug antibody (ADA) assays, created data silos and risked late error detection. The company partnered with IDBS to extend its use of the E-WorkBook platform to automate and integrate this reporting.

IDBS implemented a solution that seamlessly integrated with the customer's LIMS to automatically retrieve, collate, and format ADA study data across multiple assay tiers into a single report. This eliminated manual handling, increased data integrity, and allowed for early error detection. The solution saved an estimated one day per study report and decreased quality control review time. IDBS provided a flexible reporting tool that standardized the customer's overall process.